QTRX Stock Cash Flow Statements

Quanterix Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Quanterix Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-31	2018-03-31

cash flows from operating activities:
net income	-30,013,000	-20,504,000	-11,628,000	-7,358,000	-9,473,000	-10,072,000	-12,409,000	-7,758,000	-6,064,000	-6,103,000	-18,581,000	-35,064,000	-24,902,000	-18,153,000	-20,026,000	-15,661,000	-11,897,000	-10,104,000	-9,821,000	2,203,000	-12,302,000	-11,610,000	-10,958,000	-9,870,000	-10,563,000	-9,405,000	-7,657,000	-7,343,000	-7,202,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization expense	1,999,000	2,188,000	1,723,000	1,616,000	1,601,000	1,523,000	1,576,000	1,943,000	1,406,000	1,439,000	1,163,000	1,396,000	1,432,000	1,358,000	1,285,000	1,222,000	1,193,000	1,151,000	1,125,000	1,108,000	1,033,000	1,046,000	821,000	1,235,000	544,000	409,000	411,000	337,000	272,000
credit losses on accounts receivable	-315,000	53,000		68,000	500,000	176,000		-13,000
accretion of marketable securities	-588,000	-979,000	-1,516,000	-1,698,000	-1,962,000	-1,657,000
impairment of goodwill
operating lease right-of-use asset amortization	289,000	561,000	522,000	531,000	362,000	478,000	497,000	516,000
stock-based compensation expense	5,372,000	5,462,000	4,837,000	4,657,000	5,228,000	5,265,000	4,326,000	4,343,000	4,193,000	3,902,000	3,663,000	2,766,000	5,186,000	3,827,000	4,931,000	4,008,000	3,650,000	3,386,000	3,129,000	2,360,000	2,501,000	2,109,000	1,675,000	1,828,000	1,601,000	1,284,000	1,867,000	890,000	636,000
change in fair value of contingent consideration	-4,273,000	379,000
other operating activity	42,000	-412,000	444,000	-376,000	-68,000	55,000
changes in assets and liabilities:
accounts receivable	5,147,000	4,329,000	-1,302,000	840,000	-3,009,000	-4,233,000	-1,080,000	135,000	-2,077,000	-3,673,000	111,000	1,566,000	2,160,000	1,319,000	-5,297,000	-3,296,000	-487,000	2,227,000	9,120,000	-16,805,000	2,619,000	-1,174,000	1,109,000	-2,178,000			-1,063,000	1,075,000	1,148,000
inventory	908,000	2,085,000	166,000	-834,000	-2,341,000	-3,670,000	-2,398,000	-1,785,000	-1,092,000	-89,000	1,467,000	3,739,000	664,000	-484,000	341,000	-1,638,000	-4,466,000	-2,327,000	-1,614,000	-1,000	-2,106,000	-1,398,000	496,000	-1,038,000
prepaid expenses and other current assets	1,521,000	421,000	-275,000	-765,000	851,000	-254,000	458,000	-2,302,000
other non-current assets	355,000	-502,000	-736,000	117,000	-575,000	-21,000	-59,000	249,000	-932,000	-33,000	-50,000	-861,000	1,000	1,000	1,000	17,000	-4,000	-16,000	16,000	155,000	-5,000	32,000	0	-23,000	-1,000	3,000
accounts payable	2,397,000	399,000	135,000	-1,466,000	3,176,000	-1,122,000	241,000	1,579,000	640,000	-1,271,000	1,723,000	-3,865,000	2,086,000	-5,306,000	3,386,000	-1,012,000	2,149,000	-2,109,000	836,000	772,000	186,000	-1,145,000	1,456,000	765,000
accrued compensation and benefits, accrued expenses, and other current liabilities	5,122,000	-3,517,000	4,564,000	1,224,000	1,736,000	-6,126,000	3,400,000	2,202,000
deferred revenue	284,000	299,000	32,000	-1,180,000	-118,000	472,000	-259,000	-772,000	-375,000	2,041,000	-509,000	-3,120,000	3,272,000	2,956,000	788,000	-217,000	-306,000	1,197,000	1,842,000	-1,248,000	-430,000	671,000	-104,000	-294,000	-355,000	45,000
operating lease liabilities	-901,000	-1,157,000	-1,104,000	-1,095,000	-888,000	-988,000	-955,000	-960,000	-909,000	179,000	890,000	1,972,000	-3,041,000	-87,000	-328,000	-312,000	-283,000	-307,000	-199,000	128,000	134,000	253,000
other non-current liabilities	625,000	-2,993,000	-8,000	-28,000	29,000	10,000	54,000	-35,000	131,000	-203,000	-118,000	137,000	262,000	-271,000	-255,000			-107,000	-311,000	260,000	-260,000	-177,000	-223,000	620,000	3,366,000	6,082,000
net cash from operating activities	-5,655,000	-13,888,000	-4,302,000	-5,747,000	-4,951,000	-20,164,000	-5,984,000	-4,049,000	633,000	-9,502,000	-4,090,000	-14,547,000	-7,940,000	-21,695,000	-10,292,000	-13,777,000	-9,749,000	-14,089,000	4,654,000	-7,419,000	-7,421,000	-13,179,000	-4,535,000	-8,832,000
capex	-794,000	-734,000	-412,000	-1,031,000	-859,000	-284,000	-2,216,000	-788,000	-648,000	11,000	-1,595,000	-3,677,000	-5,060,000	-1,394,000	-2,530,000	-3,824,000	-9,712,000	3,262,000	-1,110,000	-465,000	-1,002,000	-324,000	-603,000	-1,014,000
free cash flows	-6,449,000	-14,622,000	-4,714,000	-6,778,000	-5,810,000	-20,448,000	-8,200,000	-4,837,000	-15,000	-9,491,000	-5,685,000	-18,224,000	-13,000,000	-23,089,000	-12,822,000	-17,601,000	-19,461,000	-10,827,000	3,544,000	-7,884,000	-8,423,000	-13,503,000	-5,138,000	-9,846,000
cash flows from investing activities:
purchases of marketable securities	1,000	-30,246,000		-81,628,000	-51,455,000	-137,889,000
proceeds from sales and maturities of marketable securities	62,613,000	73,261,000
purchases of property and equipment	-777,000	-1,256,000	-412,000	-851,000	-1,599,000	-506,000	-2,216,000	-788,000	-648,000	-136,000	-1,595,000	-3,677,000	-5,060,000	-1,394,000	-2,453,000	-3,824,000	-7,260,000	-79,000	-1,781,000	-788,000	-935,000	-426,000	-544,000	-473,000
acquisition, net of cash acquired	43,000	-8,997,000
net cash from investing activities	61,880,000	32,762,000	32,384,000	-12,429,000	6,975,000	-109,195,000	-21,629,000	-125,988,000	-648,000	-136,000	-1,595,000	-3,677,000	-5,060,000	-874,000	-2,194,000	-2,015,000	-4,564,000	2,435,000	1,523,000	-788,000	-935,000	-426,000	-544,000	-15,002,000	-3,913,000	-5,917,000
cash flows from financing activities:
proceeds from common stock issued under stock plans	0	668,000	67,000	578,000	384,000	2,037,000	257,000	1,855,000
payments for employee taxes withheld on stock-based compensation awards	-429,000	-575,000	-26,000	-434,000	-712,000	-1,438,000	-56,000	-55,000
net cash from financing activities	-429,000	93,000	41,000	144,000	-328,000	599,000	201,000	1,800,000	139,000	551,000	714,000	407,000	211,000	979,000	-851,000	-4,060,000	2,393,000	273,313,000	2,076,000	92,684,000	615,000	861,000	724,000	65,201,000
net increase in cash, cash equivalents, and restricted cash	55,796,000	18,967,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	594,000	861,000	-752,000	371,000	27,000	-380,000	530,000	-66,000
cash, cash equivalents, and restricted cash at beginning of period	0	59,319,000	0	0	0	177,026,000	0	0
cash, cash equivalents, and restricted cash at end of period	56,390,000	79,147,000	27,371,000	-17,661,000	1,723,000	47,886,000	-26,882,000	-128,303,000
supplemental disclosure of cash flow information:
cash paid for taxes	385,000	505,000	172,000	189,000	339,000	175,000	89,000	217,000
right-of-use asset obtained in exchange for lease liabilities											255,000			18,156,000
purchases of property and equipment in accounts payable and accrued expenses	-17,000	522,000		-180,000	740,000	222,000
credit losses (gains) on accounts receivable
impairment
purchases of marketable debt securities
proceeds from maturities of marketable securities			57,430,000	70,050,000	60,029,000	29,200,000
proceeds from radx grant on assets purchased											0	0	0	520,000	259,000	1,809,000	2,696,000	2,514,000
net decrease in cash, cash equivalents, and restricted cash			28,123,000	-18,032,000	1,696,000	-128,760,000		-128,237,000
purchases of property and equipment in accounts payable and accruals
operating lease right-of-use assets obtained in exchange for lease liabilities
non-cash consideration received under product sales agreement
shares received as consideration under product sales agreement								-225,000

proceeds from marketable debt securities
sale of common stock in underwritten public offering															0	0	0	269,718,000	0
payments on notes payable															-1,994,000				0	0	0	-75,000	0	0
cash paid for interest															0	80,000	155,000	154,000	157,000	313,000	0	155,000	178,000	318,000	0	160,000	159,000	166,000	181,000
foreign currency losses								154,000
unrealized losses on marketable securities
amortization of (discount) premium on marketable securities
deferred income taxes								-101,000
loss on disposal of fixed assets																				51,000	0	69,000		10,000
operating activities
credit (income) loss expense on accounts receivable										110,000
unrealized losses (gains) on foreign currency transactions										63,000
non-cash operating lease expense										334,000
deferred taxes										207,000
changes in operating assets and liabilities:
prepaid expenses and other assets										-422,000	-306,000	-1,192,000	3,000,000	-2,070,000	1,002,000	1,557,000	-1,208,000	-1,744,000	-3,922,000	-121,000	611,000	-495,000	393,000	-406,000	160,000	142,000
accrued compensation and benefits, other accrued expenses and other current liabilities										-5,983,000	-955,000	1,366,000	534,000	-4,921,000	3,798,000	1,188,000	1,673,000	-5,598,000	4,102,000	3,125,000	702,000	-1,710,000	249,000	-96,000
investing activities
financing activities
proceeds from stock options exercised										13,000	714,000	120,000	211,000	385,000	1,143,000	1,138,000	2,393,000	3,076,000	2,076,000	832,000	615,000	496,000	644,000	266,000	1,407,000	503,000	303,000	297,000	84,000
proceeds from espp purchase										551,000	0	287,000	0	594,000	0	546,000	0	519,000	0	448,000	0	440,000	80,000	406,000	65,000	328,000
payments for employee taxes on units withheld										-13,000
net increase in cash, cash equivalents and restricted cash										-9,087,000		-17,817,000	-12,789,000	-21,590,000
effect of foreign currency exchange rate on cash										24,000	-31,000	269,000	-218,000	-558,000	-26,000	77,000	28,000	-171,000	169,000	-121,000	188,000	-78,000	183,000
cash, cash equivalents and restricted cash at beginning of period										341,337,000
cash, cash equivalents and restricted cash at end of period										332,274,000
cash paid for income taxes										246,000
noncash transactions:
purchases of property and equipment included in accounts payable and accrued expenses										147,000
reconciliation of cash, cash equivalents and restricted cash:
cash and cash equivalents										329,354,000	-5,003,000	-17,550,000	-13,024,000	374,317,000	-14,282,000	-20,033,000	-11,892,000	442,672,000	8,422,000	84,356,000	-7,553,000	96,359,000	-4,172,000	41,302,000	38,053,000	33,972,000
restricted cash										2,920,000	1,000	2,000	17,000	2,577,000	919,000	258,000	0	1,400,000	0	0	0	1,000,000	0	0	7,000	1,019,000
total cash, cash equivalents, and restricted cash										332,274,000	-5,002,000	-17,548,000	-13,007,000	376,894,000	-13,363,000	-19,775,000	-11,892,000	444,072,000	8,422,000	84,356,000	-7,553,000	97,359,000	-4,172,000	41,302,000	38,060,000	34,991,000
inventory step-up amortization															0	0	111,000	164,000	52,000	476,000	-244,000	438,000
non-cash lease expense
goodwill impairment											0
impairment of long-lived assets
non-cash interest expense															0	22,000	21,000	22,000	21,000	22,000	21,000	22,000	21,000	22,000	22,000	24,000	34,000	46,000	53,000
net increase in cash and cash equivalents															-13,337,000	-19,852,000	-11,920,000	261,659,000	8,253,000	84,477,000			-4,355,000	41,367,000
cash, restricted cash, and cash equivalents at beginning of period													0	399,042,000	0	0	0	182,584,000	0	0	0	110,181,000	0	0	0	45,429,000
cash, restricted cash, and cash equivalents at end of period													-13,007,000	376,894,000	-13,363,000	-19,775,000	-11,892,000	444,072,000	8,422,000	84,356,000	-7,553,000	97,359,000	-4,172,000	41,302,000	38,060,000	34,991,000
supplemental cash flow information
purchases of property and equipment included in accounts payable and other accrued expenses															-77,000
reconciliation of cash, cash equivalents, and restricted cash:
credit loss expense on accounts receivable												-479,000	752,000	-171,000	-73,000	266,000	0	20,000
impairment expense
other non-cash items
cash, cash equivalents and restricted stock at beginning of period
cash, cash equivalents and restricted stock at end of period
reduction in the carrying amount of right-of-use assets													577,000	348,000
contract acquisition costs													71,000	-41,000	-69,000	-51,000	0	-72,000	186,000	0	11,000	-110,000	-197,000	593,000
reduction in the carrying amounts of right-of-use assets															135,000	118,000	118,000	128,000	41,000	96,000
acquisitions, net of cash acquired																							0
sale of common stock in at-the-market offering
purchase of property and equipment included in other non-current liabilities
common stock issued in connection with the acquisition of umandiagnostics ab
deferred tax liabilities
purchases of property and equipment included in accounts payable																	-2,452,000	3,341,000	671,000	323,000	-67,000	102,000	119,000	-234,000	268,000	11,000
gain on disposal of fixed assets
purchase of investments
proceeds from sale of assets
proceeds from sale of common stock, net of issuance costs
purchases of property and equipment included in other non-current liabilities																							-178,000	-307,000
191,152 shares of common stock issued in connection with the acquisition of umandiagnostics ab
fair value of common stock warrants exercised and reclassified as shares of common stock
acquisition of umandiagnostics ab, net of cash acquired
net decrease in cash and cash equivalents																						-12,744,000
inventory valuation adjustment amortization
change in fair value of preferred stock warrants
deposits
proceeds from sale of preferred stock, net of issuance costs
proceeds from exercise of stock warrants
proceeds from the issuance of notes payable and warrants, net of issuance costs
accretion of redeemable convertible preferred stock to redemption value
warrants issued to lenders
net proceeds from at-the-market offering																								0
net proceeds from underwritten public offering
191,152 shares of common stock issued in connection with the acquisition of uman
net cash provided (used in) by financing activities																										831,000
accrued compensation and benefits, other accrued expenses and other liabilities
proceeds from the issuance of long term debt and warrants, net of issuance costs
payments on long term debt
cash and cash equivalents at beginning of period																												0	79,682,000
cash and cash equivalents at end of period																												-4,757,000	65,231,000

We provide you with 20 years of cash flow statements for Quanterix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Quanterix stock. Explore the full financial landscape of Quanterix stock with our expertly curated income statements.

The information provided in this report about Quanterix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.